March 2011

Condolences

Thursday, March 31, 2011

We deeply regret informing our readers of the recent deaths of Thomas Littlejohn, M.D. and Donna Beardsworth. Both Tommy and Donna devoted their professional lives to serving the clinical research enterprise:

[Read More]

Cephalon announces takeover bid for ChemGenex

Wednesday, March 30, 2011

Cephalon and ChemGenex Pharmaceuticals announced that Cephalon’s wholly-owned subsidiary, Cephalon CXS Holdings, intends to make a takeover bid for ChemGenex. ChemGenex is a hematology-focused Australian biopharmaceutical company developing its lead product candidate, Omapro, for the treatment of chronic myeloid leukemia (CML) patients. Omapro recently completed phase III clinical trials and ChemGenex plans to file a new drug application with the FDA in the second half of 2011.

[Read More]

Heart failure studies often exclude older patients

Wednesday, March 30, 2011

Many cases of heart failure occur in adults aged 65 and older, but a recent report found that several clinical trials examining heart failure excluded older patients, according to Reuters.  This suggests the medications developed for the condition are not tested on the patient population who will be taking the drugs.

[Read More]

Heart failure studies often exclude older patients

Tuesday, March 29, 2011

Many cases of heart failure occur in adults aged 65 and older, but a recent report found that several clinical trials examining heart failure excluded older patients, according to Reuters.  This suggests the medications developed for the condition are not tested on the patient population who will be taking the drugs.

[Read More]